Because the effectiveness of the current oral options ... review discusses various topical antibiotic treatment options for uncomplicated skin infections, including over-the-counter and prescribed ...

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...

Both mupirocin and retapamulin demonstrated high clinical success rate in SIDs, but did not show significant superiority to oral antimicrobials ... treatment failure or re-infection, especially ...

The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...

The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...

oral antibiotic for adult and adolescent females with uncomplicated urinary tract infections (uUTIs). The FDA has granted Priority Review for this application and assigned a Prescription Drug User ...

The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial ...

FDA accepted GSK's gepotidacin application for uUTI treatment ... an investigational, oral antibiotic for adult and adolescent females with uncomplicated urinary tract infections (uUTIs).

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...

The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.